Objective: To investigate the frequency of apoE alleles among women with po
lycystic ovary syndrome.
Design: Retrospective case-control study.
Setting: University-based endocrinology/infertility clinic.
Patient(s): Healthy fertile women (n = 91) and women with a diagnosis of po
lycystic ovary syndrome (n = 58).
Intervention(s): None.
Main Outcome Measure(s): The presence of the three most common apoE alleles
(epsilon2, epsilon3, and epsilon4) determined by polymerase chain reaction
-restriction fragment length polymorphism in the two groups and in the gene
ral population in our area.
Result(s): The frequency of the apo epsilon4 allele was 17.2% among women w
ith polycystic ovary syndrome and was 18.7% among healthy fertile women, wh
ich is close to the rate in the general population in our area (19%). None
of the apoE genotypes (Fisher s exact test: P = .71) or alleles (P = .78) w
as significantly overrepresented, and the homozygous genotype epsilon4 was
not associated with the clinical disease.
Conclusion(s): The observed profiles of allele and genotype frequencies con
firm the equilibrium state between apoE polymorphism and polycystic ovary s
yndrome and suggest that apoE does not play a major role in the development
of hyperlipidemia in the group of women with polycystic ovary syndrome. (F
ertil Steril(R) 2001:75:878-80. (C)2001 by American Society for Reproductiv
e Medicine.).